Voyager Therapeutics, Inc. announced the appointment of Jane Pritchett Henderson as senior vice president and chief financial officer effective January 1, 2017.  Ms. Henderson brings more than 28 years of life sciences industry and banking experience and leadership to her new role. Ms. Henderson most recently served as chief financial and business officer of Kolltan Pharmaceuticals, Inc., having joined the privately-held biopharmaceutical company in 2013 and leading the sale of Kolltan to Celldex Pharmaceuticals, Inc., in late 2016.  Previously, Ms. Henderson served as vice president, business development of ISTA Pharmaceuticals, Inc., from June 2010 to June 2012, when ISTA Pharmaceuticals was acquired by Bausch + Lomb.